CC
AMRX icon

Corton Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

Corton Capital’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,542
Closed -$126K – 204
2025
Q2 		$126K Sell
15,542
-7,881
-34% -$59.4K 0.15% 295
2025
Q1 		$196K Buy
+23,423
New +$196K 0.65% 69
2024
Q3 		– Sell
-19,051
Closed -$121K – 477
2024
Q2 		$121K Buy
+19,051
New +$121K 0.06% 438

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Corton Capital's AMRX Position: Q3 2025 in Review

Corton Capital sold out of Amneal Pharmaceuticals (AMRX) in Q3 2025, closing a stake of 15,542 shares — an estimated $126K sold.

Corton Capital first reported a position in AMRX in Q2 2024 and held it in 3 quarters. The position peaked at $196K in Q1 2025. 248 funds tracked by Wall St. Rank hold AMRX as of Q3 2025.

  • Corton Capital reported no remaining Amneal Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Corton Capital sold 15,542 Amneal Pharmaceuticals shares in Q3 2025, an estimated $126K.
  • Corton Capital first reported a position in Amneal Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Corton Capital's Amneal Pharmaceuticals position peaked at $196K in Q1 2025.
  • 248 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.